Research programme: GABA-A modulating steroid receptor antagonists - Umecrine Cognition/CleveXel PharmaAlternative Names: CVXL-0060
Latest Information Update: 13 Oct 2014
At a glance
- Originator Umecrine Cognition
- Developer CleveXel Pharma; Umecrine Cognition
- Class Small molecules
- Mechanism of Action GABA-A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Hepatic encephalopathy